Effects of Brain Stimulation During Nocturnal Sleep on Memory Consolidation in Patients With Mild Cognitive Impairments
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The beneficial effect of nocturnal sleep on memory consolidation is well-documented in young, healthy subjects. Especially, periods rich in slow-wave sleep (SWS) have shown a memory enhancing effect on hippocampus-dependent declarative memory. Slow oscillatory activity typically occuring during SWS has been implicated in the consolidation effect. Recent evidence in young healthy subjects suggest that the sleep-associated consolidation effect can be amplified by the application of a weak transcranial oscillatory electric current within the frequency range of SWS in humans (0,7-0,8 Hz) during SWS. If patients with amnestic mild cognitive impairments (MCI)- usually characterized by initial difficulties in hippocampus dependent memory functions - benefit from transcranial slow oscillatory stimulation (tSOS) during nocturnal sleep as well has not been studied so far. The primary aim of the present study is to investigate the influence of a weak slow oscillating brain stimulation (tSOS) on declarative memory consolidation applied during periods of nocturnal SWS in MCI patients.
| Condition | Intervention |
|---|---|
|
Mild Cognitive Impairment, So Stated |
Device: Stimulation Device: SHAM |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Caregiver, Investigator) Primary Purpose: Treatment |
| Official Title: | Impact of Transcranial Slow Oscillating Stimulation on Memory Consolidation During Nocturnal Slow Wave Sleep in Patients With Mild Cognitive Impairments(MCI) |
- Retention of declarative memories after 0.75 Hz stimulation during SWS, vs after sham stimulation during SWS [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]Retention between stimulation conditions (0.75 Hz during SWS, vs sham stimulation during SWS) in the declarative memory task.
- Amount of Slow wave Sleep, spindels, eeg-correlates, further memory systems [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
- Amount of slow wave sleep assessed by standard polysomnographic criteria in 0,75 Hz vs SHAM stimulation during SWS.
- Spindel activity during sleep indicated via several spindel parameters like number, duration, frequency of spindles; compared between 0,75 Hz and SHAM stimulation during SWS.
- Neuronal correlates (EEG-power in slow oscillation frequency bands induced by 0,75 Hz vs SHAM stimulation during SWS; EEG-correlates of encoding and retrieval of a declarative memory task).
- Performance in further memory systems (procedural), compared between 0,75 Hz and SHAM stimulation during SWS.
| Estimated Enrollment: | 22 |
| Study Start Date: | April 2013 |
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | February 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 0,75 Hz stimulation
slow transcranial oscillating stimulation (~0,75Hz) during periods of Slow Wave Sleep
|
Device: Stimulation
Other Name: oscillating direct current brain stimulation
|
|
Sham Comparator: SHAM stimulation
SHAM stimulation during periods of Slow Wave Sleep
|
Device: SHAM
no stimulation
|
Eligibility| Ages Eligible for Study: | 50 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
amnestic and amnestic plus MCI-patients:
- Concern reflecting a change in cognition reported by patient or informant or clinician (i.e., historical or observed evidence of decline over time)
- Objective evidence of memory impairment; additional cognitive domains may be affected as well;
- Preservation of independence in functional abilities
- no dementia
- age: 50-80 years
Exclusion Criteria:
- untreated severe internal or psychiatric diseases
- epilepsy
- other severe neurological diseases eg., previous major stroke, brain tumour
- dementia
- contraindications to MRI
Contacts and Locations| Contact: Sven Paßmann, M.sc. | 030/450 560 395 | sven.passmann@charite.de |
| Contact: Nadine Külzow, PhD | 030/450 560 140 | nadine.kuelzow@charite.de |
| Germany | |
| Charite CCM Neurologie Berlin | Recruiting |
| Berlin, Germany, 10117 | |
| Contact: Sven Paßmann, M.sc. +49/30/450560395 sven.passmann@charite.de | |
| Contact: Agnes Flöel, Prof. Dr. +49/30/450560284 agnes.floeel@charite.de | |
| Sub-Investigator: Nadine Külzow, Dr. | |
| Sub-Investigator: Sven Paßmann, M.sc. | |
| Principal Investigator: Agnes Flöel, Prof. Dr. | |
| Study Chair: | Agnes Flöel, Professor | Charite Universitätsmedizin Berlin - Neurologie |
More Information
Additional Information:
Publications:
| Responsible Party: | Agnes Floeel, Prof. Agnes Flöel, MD, Charite University, Berlin, Germany |
| ClinicalTrials.gov Identifier: | NCT01782391 History of Changes |
| Other Study ID Numbers: | Nighttime sleep-tSOS-MCI |
| Study First Received: | June 5, 2012 |
| Last Updated: | May 27, 2013 |
| Health Authority: | Germany: Ethics Commission |
Keywords provided by Charite University, Berlin, Germany:
|
mild cognitive impairment dementia MCI brain stimulation tSOS |
tDCS sleep memory memory consolidation |
Additional relevant MeSH terms:
|
Cognition Disorders Delirium, Dementia, Amnestic, Cognitive Disorders Mental Disorders |
ClinicalTrials.gov processed this record on June 17, 2013